Toxic epidermal necrolysis; 15.years'experience in a Dutch burns centre

Journal of the European Academy of Dermatology and Venereology

Volumn 21, Issue 6, 2007, Pages 781-788

  Gerdts, B ^a   Vloemans, A F P M ^a   Kreis, R W ^a  

^a RED CROSS HOSPITAL   (Netherlands)

Author keywords

Lyell's syndrome; Management; SCORTEN; Selective digestive decontamination; Toxic epidermal necrolysis

Indexed keywords

AMOXICILLIN; AMPHOTERICIN B; ANTIBIOTIC AGENT; ANTIHISTAMINIC AGENT; ARTIFICIAL TEAR; AZITHROMYCIN; CALCIUM CARBONATE; CARBAMAZEPINE; CEFOTAXIME; COLISTIN; CORTICOSTEROID; ETIDRONIC ACID; HYDROXYCHLOROQUINE; HYPERTENSIVE FACTOR; IMMUNOGLOBULIN; INOTROPIC AGENT; LOCAL ANESTHETIC AGENT; LUBRICATING AGENT; METHOTREXATE; OMEPRAZOLE; PARACETAMOL; PHENYTOIN; QUINAPRIL; RIZATRIPTAN; SULFADIAZINE SILVER; TOBRAMYCIN;

ABDOMINAL COMPARTMENT SYNDROME; ACUTE KIDNEY FAILURE; ADOLESCENT; ADULT; AGED; APACHE; ARTICLE; ARTIFICIAL VENTILATION; BLISTER; BURN UNIT; CHILD; CLINICAL ARTICLE; CONJUNCTIVITIS; CONSERVATIVE TREATMENT; DECOMPRESSION SURGERY; DISEASE SEVERITY; DRUG WITHDRAWAL; ENTERIC FEEDING; FEMALE; FLUID THERAPY; HEMOFILTRATION; HOSPITAL INFECTION; HUMAN; ILEUS; LAPAROTOMY; MALE; MEDICAL RECORD REVIEW; MULTIPLE ORGAN FAILURE; NETHERLANDS; PATIENT REFERRAL; PERITONITIS; PRIORITY JOURNAL; PROGNOSIS; TOXIC EPIDERMAL NECROLYSIS; URETHRITIS; VULVITIS; WOUND CARE; WOUND DRESSING; WOUND INFECTION;

ADOLESCENT; ADULT; AGED; BURN UNITS; CHILD; EPIDERMAL NECROLYSIS, TOXIC; HUMANS; MIDDLE AGED; NETHERLANDS; PROGNOSIS; REFERRAL AND CONSULTATION; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 34250676918     PISSN: 09269959     EISSN: 14683083     Source Type: Journal    
DOI: 10.1111/j.1468-3083.2006.02082.x     Document Type: Article

References (39)

1. Lyell A. Toxic epidermal necrolysis: An eruption resembling scalding of the skin. Br J Dermatol 1956; 68: 355-361.
2. Roujeau JC, Stern RS. Severe adverse cutaneous reactions to drugs. N Engl J Med 1994; 331: 1272-1285.
3. Revuz J, Penso D, Roujeau JC et al. Toxic epidermal necrolysis. Clinical findings and prognosis factors in 87 patients. Arch Dermatol 1987; 123: 1160-1165.
4. Fritsch PO, Sidoroff A. Drug-induced Stevens-Johnson syndrome/toxic epidermal necrolysis. Am J Clin Dermatol 2000; 1: 349-360.
5. Chan HL, Stern RS, Arndt KA et al. The incidence of erythema multiforme, Stevens-Johnson syndrome, and toxic epidermal necrolysis. A population-based study with particular reference to reactions caused by drugs among outpatients. Arch Dermatol 1990; 126: 43-47.
6. Auquier-Dunant A, Mockenhaupt M, Naldi L et al. Correlations between clinical patterns and causes of erythema multiforme majus, Stevens-Johnson syndrome, and toxic epidermal necrolysis. Arch Dermatol 2002; 138: 1019-1024.
7. Haber J, Hopman W, Gomez M, Cartotto R. Late outcomes in adult survivors of toxic epidermal necrolysis after treatment in a burn center. J Burn Care Rehabil 2005; 26: 33-41.
8. Knaus WA, Draper EA, Wagner DP et al. APACHE II: A severity of disease classification system. Crit Care Med 1985; 13: 818-829.
9. Bastuji-Garin S, Fouchard N, Bertocchi M et al. SCORTEN: A severity-of-illness score for toxic epidermal necrolysis. J Invest Dermatol 2000;115: 149-153.
10. Khoo AK, Foo CL. Toxic epidermal necrolysis in a burns centre: A 6-year review. Burns 1996; 22: 275-278.
11. Stoutenbeek CP, van Saene HK, Miranda DR et al. The effect of oropharyngeal decontamination using topical nonabsorbable antibiotics on the incidence of nosocomial respiratory tract infections in multiple trauma patients. J Trauma 1987; 27: 357-364.
12. de Jonge E, Schultz MJ, Spanjaard L et al. Effects of selective decontamination of digestive tract on mortality and acquisition of resistant bacteria in intensive care: A randomised controlled trial. Lancet 2003; 362: 1011-1016.
13. de La Cal MA, Cerda E, Garcia-Hierro P et al. Survival benefit in critically ill burned patients receiving selective decontamination of the digestive tract: A randomized, placebo-controlled, double-blind trial. Ann Surg 2005; 241: 424-430.
14. Bower RH, Talamini MA, Sax HC et al. Postoperative enteral vs. parenteral nutrition. A randomized controlled trial. Arch Surg 1986; 121: 1040-1045.
15. Trice S, Melnik G, Page CP. Complications and costs of early postoperative parenteral versus enteral nutrition in trauma patients. Nutrition Clin Prac 1999; 12: 114-119.
16. Marvin JA, Heimbach DM, Engrav LH, Harnar TJ. Improved treatment of the Stevens-Johnson syndrome. Arch Surg 1984; 119: 601-605.
17. Roujeau JC. Clinical heterogeneity of drug hypersensitivity. Toxicology 2005; 209: 123-129.
18. Nassif A, Bensussan A, Boumsell L et al. Toxic epidermal necrolysis: effector cells are drug-specific cytotoxic T cells. J Allergy Clin Immunol 2004; 114: 1209-1215.
19. Paquet P, Piérard EP, Quatresooz P. Novel treatments for drug-induced toxic epidermal necrolysis (Lyell's syndrome). Int Arch Allergy Immunol 2005; 136: 205-216.
20. Nirken MH. Stevens-Johnson syndrome and toxic epidermal necrolysis in adults. Uptodate 2004; 3.
21. Tripathi A, Ditto AM, Grammer LC et al. Corticosteroid therapy in an additional 13 cases of Stevens-Johnson syndrome: A total series of 67 cases. Allergy Asthma Proc 2000; 21: 101-105.
22. Kakourou T, Klontza D, Soteropoulou F, Kattamis C. Corticosteroid treatment of erythema multiforme major (Stevens-Johnson syndrome) in children. Eur J Pediatr 1997; 156: 90-93.
23. Halebian PH, Corder VJ, Madden MR et al. Improved burn center survival of patients with toxic epidermal necrolysis managed without corticosteroids. Ann Surg 1986; 204: 503-512.
24. Rasmussen JE. Erythema multiforme in children. Response to treatment with systemic corticosteroids. Br J Dermatol 1976; 95: 181-186.
25. Ginsburg CM. Stevens-Johnson syndrome in children. Pediatr Infect Dis 1982; 1: 155-158.
26. Viard I, Wehrli P, Bullani R et al. Inhibition of toxic epidermal necrolysis by blockade of CD95 with human intravenous immunoglobulin. Science 1998; 282: 490-493.
27. Trautmann A, Akdis D, Schmid-Grendelmeier P et al. Targeting keratinocyte apoptosis in the treatment of atopic dermatitis and allergic contact dermatitis. J Allergy Clin Immunol 2001; 108: 839-846.
28. Prins C, Kerdel FA, Padilla RS et al. Treatment of toxic epidermal necrolysis with high-dose intravenous immunoglobulins: Multicenter retrospective analysis of 48 consecutive cases. Arch Dermatol 2003; 139: 26-32.
29. 0Trent JT, Kirsner RS, Romanelli P, Kerdel FA. Analysis of intravenous immunoglobulin for the treatment of toxic epidermal necrolysis using SCORTEN: The University of Miami experience. Arch Dermatol 2003; 139: 39-43.
30. Bachot N, Revuz J, Roujeau JC. Intravenous immunoglobulin treatment for Stevens-Johnson syndrome and toxic epidermal necrolysis: A prospective noncomparative study showing no benefit on mortality or progression. Arch Dermatol 2003; 139: 33-36.
31. Brown KM, Silver GM, Halerz M et al. Toxic epidermal necrolysis: Does immunoglobulin make a difference ? J Burn Care Rehabil 2004; 25: 81-88.
32. Wolkenstein P, Latarjet J, Roujeau JC et al. Randomised comparison of thalidomide versus placebo in toxic epidermal necrolysis. Lancet 1998; 352: 1586-1589.
33. Schopf E, Stuhmer A, Rzany B et al. Toxic epidermal necrolysis and Stevens-Johnson syndrome. An epidemiologic study from West Germany. Arch Dermatol 1991; 127: 839-842.
34. Schulz JT, Sheridan RL, Ryan CM et al. A 10-year experience with toxic epidermal necrolysis. J Burn Care Rehabil 2000; 21: 199-204.
35. Ducic I, Shalom A, Rising W et al. Outcome of patients with toxic epidermal necrolysis syndrome revisited. Plast Reconstr Surg 2002; 110: 768-773.
36. Palmieri TL, Greenhalgh DG, Saffle JR et al. A multicenter review of toxic epidermal necrolysis treated in U.S. burn centers at the end of the twentieth century. J Burn Care Rehabil 2002; 23: 87-96.
37. Westly ED, Wechsler HL. Toxic epidermal necrolysis. Granulocytic leukopenia as a prognostic indicator. Arch Dermatol 1984; 120: 721-726.
38. D'Amico R, Pifferi S, Leonetti C et al. Effectiveness of antibiotic prophylaxis in critically ill adult patients: Systematic review of randomised controlled trials. BMJ 1998; 316: 1275-1285.
39. Nathens AB, Marshall JC. Selective decontamination of the digestive tract in surgical patients: A systematic review of the evidence. Arch Surg 1999; 134: 170-176.